New hopes for the treatment of primary ovarian insufficiency/ premature ovarian failure

Journal of Reproduction and Infertility

Volumn 14, Issue 1, 2013, Pages 1-2

  Sadeghi, Mohammad Reza ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; FOLLITROPIN;

AUTOIMMUNITY; CANCER PATIENT; CELL PROLIFERATION; CRYOPRESERVATION; EDITORIAL; ENDOCRINE FUNCTION; ENVIRONMENTAL FACTOR; FEMALE FERTILITY; HEREDITY; HORMONE SUBSTITUTION; HUMAN; MENOPAUSE; NONHUMAN; OOCYTE DEVELOPMENT; OVARIAN PRESERVATION; OVARY FUNCTION; PREGNANCY; PREMATURE OVARIAN FAILURE; SPERMATOGENESIS; STEM CELL NICHE; SURVIVAL RATE;

EID: 84872930636     PISSN: 22285482     EISSN: 2251676X     Source Type: Journal    
DOI: None     Document Type: Editorial

References (3)

1. Blumenfeld Z. Fertility treatment in women with premature ovarian failure. Expert Rev Obstet Gynecol. 2011;6(3): 321-30.
2. Sadri-Ardekani H, Akhondi MA, van der Veen F, Repping S, van Pelt AM. In vitro propagation of human prepubertal spermatogonial stem cells. JAMA. 2011;305(23):2416-8.
3. White YA, Woods DC, Takai Y, Ishihara O, Seki H, Tilly JL. Oocyte formation by mitotically active germ cells purified from ovaries of reproductive-age women. Nat Med. 2012;18(3):413-21.